Please email commercialreprints@urotoday.com with questions on pricing for reprints. Reprints are available for all articles published in the UroToday International Journal.

UIJ Policy and Procedures

1. Single-article reprints are subject to the UroToday and UroToday International Journal Fundamental Principles and approval process.
2. With only rare exceptions, reprints must include a front cover that includes the following:
   • Name/logo of journal
   • Title of article, complete list of authors, and issue date
   • The phrase “A Reprint From” or its translation must appear at the top of the cover. No other content is permitted on the front cover.
3. Prescribing information or disclaimers required or approved by a government regulatory body (eg, US Food and Drug Administration [FDA]) or the purchasing company's inventory numbers may be included subject to the UIJ Fundamental Principles and approval process. When prescribing information is required to be included, the printed product will consist of the article followed by a buffer page and then by the prescribing information. The buffer page will include a statement similar to the following:

   “This reprint is provided courtesy of [company name], which has a financial interest in the product/topic discussed in this article. The following FDA-approved labeling has been provided by [company name]. UroToday and UroToday International Journal do not assume responsibility for the content of the following information."

   Note: the above statement is permitted only on the buffer page for approved prescribing information.
4. Reprint holders and all materials contained therein (cover letters and other materials printed as part of, attached to, or surrounding a reprint) are subject to the UroToday and UroToday International Journal Fundamental Principles and approval process.